Assessing benefit in trials: Are we making progress in assessing progression in cancer clinical trials?

E-ISSN： 1097-0142|121|11|1728-1730

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.11, 2015-06, pp. : 1728-1730

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Benefit Response in Pancreatic Cancer Trials Revisited

Oncology Research and Treatment, Vol. 37, Iss. 1-2, 2014-01 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

A Meta‐analysis of Randomized Clinical Trials Assessing Hemodialysis Access Thrombosis Based on Access Flow Monitoring: Where Do We Stand?

SEMINARS IN DIALYSIS, Vol. 28, Iss. 2, 2015-03 ,pp. : E23-E29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain

By Silberstein S. D.

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 861-867

Informa Healthcare

Access to resources Recommend Favorite

Translating clinical trials into clinical practice: a survey assessing the potential impact of the Pediatric Heart Network Infant Single Ventricle Trial

Cardiology in the Young, Vol. 27, Iss. 7, 2017-02 ,pp. : 1265-1270

Cambridge University Press

Access to resources Recommend Favorite

Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods

By Marcellin Fabienne Spire Bruno Carrieri Maria Patrizia Roux Perrine

Expert Review of Anti-Infective Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 239-250

Informa Healthcare

Access to resources Recommend Favorite